Drawing for Serial No. 79163812

USPTO serial 79163812

Serial No. 79163812

Reviewed by CopyMark Law Group

Reg. 4843473Status 404
Filing date
Status date
Registration date
Nov 3, 2015
Examiner
MAI, TINA HSIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with Serial No. 79163812?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Max Vern

Max Vern Amster, Rothstein & Ebenstein LLP90 Park AvenueNew York, NY 10016UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Chemicals used in industry; chemicals used in science; carbonic hydrates; raw materials, namely, animal or vegetable albumin for industrial use; raw material, namely, animal albumen for industrial use; chemicals for use in industry, namely, cellulose derivatives; chemical reagents, other than for medical or veterinary purposes; stem cells other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposesSECTION 71 - CANCELLED—
005Pharmaceutical preparations including cell-based preparations for medical purposes including stem cells for the treatment of endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biocides; biological preparations for the prevention and treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; medicines for use by humans, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; albuminous preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; stem cells for medical purposes; surgical dressings; diagnostic preparations for medical purposes; chemical preparations for medical purposes, namely, for use in the treatment of infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases and disorders; biological tissue cultures for medical purposesSECTION 71 - CANCELLED—
010Medical apparatus and instruments for treating cardiovascular, infectious, endocrine, nutritional, metabolic, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hematological, dermatological, neurological and immune system related diseases; testing apparatus for medical purposes in the field of cancer, hepatology, ophthalmology, gastroenterology, hematology, dermatology, neurology, immunology, and infectious diseases; suture materials; surgical thread; surgical implants comprised of artificial materials; surgical cell implants comprised of natural, non-living materials; surgical implants consisting primarily of artificial materials and also including biological materials; cell implants made of artificial materials; cell implants comprised of natural, non-living materials; cell implants consisting primarily of artificial materials and also including biological materialsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 29, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Aug 29, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Apr 4, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 5, 2023XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 5, 2023XXCRGENERIC MADRID TRANSACTION CREATED—
Jan 20, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 20, 2022C71TCANCELLED SECTION 71—
Nov 3, 2020REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
May 27, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 17, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Mar 17, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Feb 3, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 23, 2015CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Nov 7, 2015CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Nov 3, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 21, 2015GPNXNOTIFICATION PROCESSED BY IB—
Aug 18, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 5, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 5, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 29, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 15, 2015ALIEASSIGNED TO LIE—
Jul 1, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2015TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 10, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 10, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 10, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2015RFNTREFUSAL PROCESSED BY IB—
May 20, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 20, 2015RFRRREFUSAL PROCESSED BY MPU—
May 20, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
May 19, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 18, 2015DOCKASSIGNED TO EXAMINER—
May 18, 2015DOCKASSIGNED TO EXAMINER—
May 1, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 27, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 23, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance